Jordi Milá

751 total citations
17 papers, 244 citations indexed

About

Jordi Milá is a scholar working on Immunology and Allergy, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jordi Milá has authored 17 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology and Allergy, 5 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jordi Milá's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Food Allergy and Anaphylaxis Research (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Jordi Milá is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Food Allergy and Anaphylaxis Research (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Jordi Milá collaborates with scholars based in Spain and United States. Jordi Milá's co-authors include R. Vilella, Jordi Vives, Francisco Lozano, Jaume Martorell, Federico Oppenheimer, Lourdes Places, Marta Crespo, Jordi Yagüe, José Alberola‐Ila and Manel Juan and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and International Journal of Cancer.

In The Last Decade

Jordi Milá

17 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jordi Milá Spain 11 113 96 56 43 42 17 244
Oliver Eltherington United Kingdom 4 251 2.2× 14 0.1× 63 1.1× 57 1.3× 32 0.8× 4 325
Cornelis E. Hack Netherlands 7 148 1.3× 26 0.3× 52 0.9× 20 0.5× 17 0.4× 8 295
Robert Dingman United States 8 80 0.7× 57 0.6× 80 1.4× 25 0.6× 59 1.4× 13 234
David M. Ellison United States 5 61 0.5× 10 0.1× 71 1.3× 51 1.2× 54 1.3× 7 173
Winnie L. Kan Australia 5 129 1.1× 16 0.2× 64 1.1× 76 1.8× 23 0.5× 10 252
Julie Pegon France 6 132 1.2× 15 0.2× 79 1.4× 20 0.5× 23 0.5× 7 357
Allison Hanlon United States 9 54 0.5× 6 0.1× 108 1.9× 71 1.7× 5 0.1× 19 234
Tatiana Jofra Italy 12 356 3.2× 5 0.1× 82 1.5× 88 2.0× 6 0.1× 24 514
Simone Dertschnig United Kingdom 8 188 1.7× 10 0.1× 45 0.8× 59 1.4× 5 0.1× 11 286
Carole Sanchez France 9 205 1.8× 21 0.2× 39 0.7× 103 2.4× 8 0.2× 15 323

Countries citing papers authored by Jordi Milá

Since Specialization
Citations

This map shows the geographic impact of Jordi Milá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Milá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Milá more than expected).

Fields of papers citing papers by Jordi Milá

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Milá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Milá. The network helps show where Jordi Milá may publish in the future.

Co-authorship network of co-authors of Jordi Milá

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Milá. A scholar is included among the top collaborators of Jordi Milá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Milá. Jordi Milá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pascal, Mariona, Rosa Muñoz‐Cano, Jordi Milá, et al.. (2016). Nonsteroidal anti‐inflammatory drugs enhance IgE‐mediated activation of human basophils in patients with food anaphylaxis dependent on and independent of nonsteroidal anti‐inflammatory drugs. Clinical & Experimental Allergy. 46(8). 1111–1119. 29 indexed citations
2.
Maurel, Joan, Miguel Caballero‐Baños, Jordi Milá, et al.. (2015). Phase II randomized trial of autologous tumor lysate dendritic cell vaccine (ADC) plus best supportive care (BSC) compared with BSC, in pre-treated advanced colorectal cancer patients.. Journal of Clinical Oncology. 33(15_suppl). 3048–3048. 8 indexed citations
3.
Puig‐Butillé, Joan Anton, Federico Simonetta, Célia Bádenas, et al.. (2012). Molecular characterization of human cutaneous melanoma-derived cell lines.. PubMed. 32(4). 1245–51. 11 indexed citations
4.
Bartra, Joan, Mariona Pascal, R. Vilella, et al.. (2011). In Vitro Evidence Of The Synergistic Effect Of Non Steroidal Anti Inflammatory Drugs (NSAIDs) Into Ig-E Mediated Food Allergy Response In Basophils. Journal of Allergy and Clinical Immunology. 127(2). AB185–AB185. 2 indexed citations
5.
Mayorga, Maritza E., Daniel Sanchı́s, Ana M. Santos, et al.. (2006). Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines. Melanoma Research. 16(2). 127–135. 13 indexed citations
6.
Crespo, Marta, Manel Solé, Juan I. Aróstegui, et al.. (2005). Diagnostic Value of C4d in Renal Allograft Biopsies in Different Clinical Settings: Absence of C4d in Grafts From Non-Heart-Beating Donors. Transplantation Proceedings. 37(9). 3688–3689. 3 indexed citations
7.
Crespo, Marta, Miquel Lozano, Manel Solé, et al.. (2003). Diagnosis and treatment of acute humoral rejection after kidney transplantation: preliminary experience. Transplantation Proceedings. 35(5). 1677–1678. 12 indexed citations
8.
Crespo, Marta, et al.. (2003). Outcome of simultaneous liver–kidney transplantation in highly sensitized, crossmatch-positive patients. Transplantation Proceedings. 35(5). 1861–1862. 22 indexed citations
9.
Vilella, R., Jordi Milá, R. Rull, et al.. (2003). Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine. International Journal of Cancer. 106(4). 626–631. 20 indexed citations
10.
García-Ortega, Pilar, et al.. (2002). Specific immune response to parietaria judaica plant profilin: a low t cell proliferative response supports high ige and skin prick test. Allergologia et Immunopathologia. 30(2). 62–69. 5 indexed citations
11.
García-Ortega, Pilar, et al.. (2001). Specific immune response to Phleum pratense plant profilin in atopic patients and control subjects. Allergologia et Immunopathologia. 29(1). 9–15. 6 indexed citations
12.
Calvo, Javier, Olga Padilla, Lourdes Places, et al.. (1999). Relevance of individual CD5 extracellular domains on antibody recognition, glycosylation and co‐mitogenic signalling. Tissue Antigens. 54(1). 16–26. 14 indexed citations
13.
Vilella, R., et al.. (1995). Porcine epitopes recognized by mouse anti-human monoclonal antibodies.. PubMed. 27(4). 2367–8. 2 indexed citations
14.
Juan, Manel, R. Vilella, Jordi Milá, et al.. (1993). CDw50 and ICAM‐3: Two names for the same molecule. European Journal of Immunology. 23(7). 1508–1512. 32 indexed citations
16.
Vilella, R., Jordi Milá, Francisco Lozano, et al.. (1990). Involvement of the CDw50 molecule in allorecognition. Tissue Antigens. 36(5). 203–210. 30 indexed citations
17.
Vilella, R., et al.. (1984). An Antiplatelet Monoclonal Antibody That Inhibits ADP and Epinephrine-Induced Aggregation. Thrombosis and Haemostasis. 51(1). 93–96. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026